the US Government bought almost all stocks of the drug Veklury (Remdesivir, “Ramdevpir”), which is effectively used in the treatment of coronavirus COVID-19. About it writes The Guardian.
According to the newspaper, the administration of us President Donald trump bought a California biopharmaceutical company Gilead Sciences more than 500 thousand doses, which is all stocks of the company in July and 90% of the August and September stock.
Thus, according to respondents edition experts, Washington has significantly limited the access of European States, including the UK and countries around the world to this drug. “They have access to most medications, so for Europe there’s nothing left, said senior visiting research fellow at the University of Liverpool, Andrew hill. — This is the first major approved drug, and where the access mechanism?”
According to him, one way for British authorities to solve the problem with the use of “Ramdevpir”, exclusive rights to which belong to Gilead Sciences, could become compulsory license for the medication. As noted by the Guardian, it would allow Britain to start buying generic versions of this drug produced in India or Bangladesh.
According to estimates by Gilead Sciences, the use of “Ramdevpir” in the treatment of patients with COVID-19 allows to reduce the recovery period to four days. The average man needs five-day course with the use of six vials of this medication. Given the fact that in developed countries the company has established a uniform price for the drug in the amount of $390 per vial, then a full course will cost $2340.
“Ramdevpir” clinically tested on the ability to treat patients with the coronavirus COVID-19 a few months ago. Authorities in several countries, including Japan, South Korea, India, Britain and Israel approved its use. U.S. authorities in early may and did a cash advance.if emergency permission to use the “Ramdevpir” for the treatment of infected with a coronavirus.
Stories about how you tried to get help from the Russian state in terms of coronaries and what came of it, email it to COVIDemail@example.com